Current State of Cardiorenal Disease in People with Type 1 Diabetes.
This article highlights the increased risk of cardiovascular and renal disease in individuals with type 1 diabetes (T1D). In recent years, the treatment landscape of type 2 diabetes has been revolutionized beyond strictly glycemic and metabolic effects by drugs, which have been shown to have additional benefits, including substantial cardiovascular and renal protection. However, until very recently, individuals with T1D were excluded from most trials that evaluated cardiovascular disease (CVD) and chronic kidney disease (CKD) risk with these agents. Here we discuss the data highlighting the high CVD, heart failure (HF), and CKD risk in T1D.